LDL size and risk of coronary heart disease in elderly men and women
Related Experiment Videos
L Mykkänen1, J Kuusisto, S M Haffner
1Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, USA.
Insights
Small, dense low density lipoprotein (LDL) particle size does not predict coronary heart disease (CHD) in elderly individuals. Other factors like smoking and high blood pressure are more significant risk factors in this age group.
Area of Science:
- Cardiology
- Gerontology
- Metabolic Syndrome
Background:
- Small, dense low density lipoprotein (LDL) particles are linked to coronary heart disease (CHD) in younger populations.
- Previous studies suggest decreased LDL size predicts CHD in middle-aged individuals.
- The role of LDL size in CHD risk for older adults remains unclear.
Purpose of the Study:
- To investigate whether decreased LDL particle size predicts coronary heart disease (CHD) events in elderly individuals aged 65-74 years.
- To compare LDL particle size between elderly subjects who experienced CHD events and those who did not.
- To identify other predictors of CHD in this elderly cohort.
Main Methods:
- A prospective, nested case-control study was conducted.
- 86 elderly cases with myocardial infarction or CHD death and 172 matched controls free of CHD were analyzed.
- LDL particle size was measured using gradient gel electrophoresis.
Main Results:
- No significant difference in LDL particle size or LDL subclass phenotype B was found between cases and controls.
- Factors like smoking, increased systolic blood pressure, apolipoprotein B, and total cholesterol/high density lipoprotein cholesterol ratio were significant CHD predictors.
- LDL size was not associated with CHD risk in elderly white subjects after adjusting for diabetes status.
Conclusions:
- Decreased LDL particle size is not a predictor of coronary heart disease (CHD) events in elderly white individuals.
- Traditional risk factors such as smoking and elevated blood pressure remain significant predictors of CHD in older adults.
- The predictive value of LDL size for CHD may diminish with age.
Abstract:
A predominance of small, dense, low density lipoprotein (LDL) particles has consistently been associated with coronary heart disease (CHD) in young and middle-aged subjects in cross-sectional studies. Recently, 3 prospective, case-control studies showed that decreased LDL size is a predictor of CHD in middle-aged subjects. However, it is not known whether decreased LDL size is mainly associated with premature CHD or whether it continues to play a role in CHD risk at older ages also. We performed a prospective, nested case-control study in 86 subjects (58 nondiabetic and 28 type 2 diabetic) aged 65 to 74 years who were free of myocardial infarction at baseline and who then had a myocardial infarction or CHD death during a 3.5-year follow-up (cases) and in 172 controls matched for sex and diabetes status but who remained free of CHD during follow-up. LDL particle size determined by gradient gel electrophoresis (268.2+/-0.9 versus 268.5+/-0.7 A, P=0.782) and the proportion of subjects with LDL subclass phenotype B (20.9 versus 21. 5, P=0.914) were similar among cases and controls. Furthermore, diastolic blood pressure, total cholesterol, high density lipoprotein cholesterol, triglycerides, apolipoprotein A(1), fasting glucose, fasting insulin, waist-to-hip ratio, and body mass index were not associated with CHD risk. However, smoking and increased systolic blood pressure, apolipoprotein B levels, and the total cholesterol-high density lipoprotein cholesterol ratio were significant predictors of CHD events both in univariate and multivariate analyses. Our findings indicate that LDL size is not a predictor of CHD events in elderly white subjects after controlling for diabetes status.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Geriatric Patients
Lipid-Lowering Drugs: Statins and Miscellaneous Agents